Effects of Nicotine on Elements of Attentions in Smokers and Nonsmokers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-02-14

Study Completion Date

2009-11-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

\- Many cigarette smokers claim that smoking helps them stay alert and improves their concentration, and have reported problems in attention and concentration after quitting smoking. Some research has indicated that nicotine can enhance certain aspects of attention and memory in humans. However, more research is needed to determine how nicotine affects different elements of the brain's ability to pay attention. Knowing which aspects of attention are affected by nicotine may help produce new medications and therapies to help people successfully stop smoking.

Objectives:

* To investigate the dose-related effects of nicotine on the ability to pay attention in smokers and nonsmokers.
* To compare the effects of nicotine in smokers and nonsmokers.

Eligibility:

\- Individuals between 18 and 50 years of age who are either current smokers (at least 15 cigarettes per day on average for at least 2 years) or healthy, nonsmoking volunteers.

Design:

* The study will consist of one training session and three testing sessions. Each session will last about 2 hours.
* The training session will introduce participants to the study tests and evaluate their tolerance of the two levels of nicotine nasal spray used in the study. Smokers will receive the higher dose of nicotine to introduce them to the effects of the spray. Nonsmokers will be given first the lower dose of the spray, followed by higher dose at least 30 minutes later. Nonsmoking participants who cannot tolerate the higher dose will not continue in the study.
* At the start of each testing session, smokers will have one cigarette to standardize the time of the most recent exposure to nicotine.
* During the testing sessions, participants will receive a placebo spray, a lower dose of nicotine, or a higher dose of nicotine, and then will be asked to perform tests that evaluate mood, attention, and performance.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal Spray

NCT01136642

Drug Addiction Nicotine Dependence

COMPLETED PHASE1

Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers

NCT00429208

Nicotine Dependence Smoking Tobacco Use Disorder +1 more

UNKNOWN NA

Effects of Nicotine on Brain Activity as Measured by fMRI

NCT01037153

Nicotine Dependence Drug Abuse

COMPLETED

Effect of Nicotine on Brain Reward Pathways

NCT02346539

Depressive Disorder

COMPLETED PHASE1

Nicotine and Behavior in Adult ADHD

NCT00573248

ADHD

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective: The primary objective of this study is to investigate the dose-related effects of nicotine on various elements of attention in smokers and nonsmokers. Because no published study, to our knowledge, has reported the effects of nicotine on the ANT and ABT, we will include the CPT, a task shown to be sensitive to nicotine, as a positive control. A secondary aim is to compare the subjective and physiological effects of nicotine between smokers and nonsmokers.

Study Population: 50 smokers for a total of 30 completers (15 women, 15 men) and up to 50 nonsmokers for a total of 30 completers (15 women, 15 men).

Design: Placebo-controlled, between-groups comparison of smokers and nonsmokers. Participants will attend three experiemental sessions; a single dose of nicotine nasal spray (0, 0.5, or 1.5 mg) will be administered at each session.

Outcome Measures: Primary outcome measures will be accuracy and/or response time on the three attention tests, ANT, CPT, and ABT. Secondary outcome measures include responses to the PANAS, VAS items, and vital signs (heart rate and blood pressure). Participant demographics and smoking history will be reported using descriptive statistics.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance Related Disorder Nicotine Dependence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Primary Study Purpose

TREATMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nicotine

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. be men and women 18-50 years old
2. report smoking at least 15 cigarettes per day on average for at least 2 years
3. have a urine cotinine level greater than or equl to 200 ng/ml
4. have an estimated IQ score greater than or equal to 85
5. be medically and psychologically healthy as determined by screening criteria

1. be men and women 18-50 years old
2. report smoking less than 10 cigarettes in their life
3. have a urine cotinine level less than 30 ng/ml
4. have an estimated IQ score greater than or equal to 85
5. be medically and psychologically healthy as determined by screening criteria

Exclusion Criteria

1. be interested in reducing or quitting tobacco use
2. have been treated for nicotine dependence in the past 3 months 3) report a history of drug or alcohol dependence

4\) report consumption of more than 15 alcoholic drinks per week during the past month

5\) report use of marijuana more than once per week during the past month

6\) report use of any illicit drug, other than marijuana, during the past 6 months

7\) be currently using any medication that would interfere with the protocol

8\) be under the influence of a drug or alcohol at experimental sessions

9\) be pregnant or nursing

10\) be HIV positive.

1. report use of any tobacco products in the past 3 years
2. report a history of drug or alcohol dependence
3. report consumption of more than 15 alcoholic drinks per week during the past month
4. report use of marijuana more than once per week during the past month
5. report use of any illicit drug, other than marijuana, during the past 6 months
6. be currently using any medication that would interfere with the protocol
7. be under the influence of a drug or alcohol at experimental sessions
8. be pregnant or nursing
9. be HIV positive.

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No